These success, along with a previous report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the strategy of concentrating on ACKR3 as a singular way to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-relevant disorders. By ticking this box https://annx062vji6.goabroadblog.com/profile